6 results
Treatment Algorithm for First Time Pulmonary Embolism
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke,
Treatment Algorithm ... Embolism • Provoked ... #PE #Pulmonary # ... #Algorithm #management ... #hematology #VTE
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... thrombosis; PE = pulmonary ... embolism; GI = ... #Algorithm #Anticoagulation ... #Management #Hematology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
incidental DVT or PE in cancer ... thrombosis in cancer ... VTE #Malignancy #Cancer ... #Algorithm #Anticoagulation ... #Management #Hematology
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
Spontaneous • Calf ... Thrombophilia • Cancer ... Bloodman #VTE #anticoagulation ... #duration #management ... #DVT #hematology
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Thromboembolism Treatment Algorithm ... at 3 Months • Cancer ... Thromboembolism #Treatment #Algorithm ... #management #hematology ... #anticoagulation
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
JAK2, CALR-calreticulin ... • Treatment algorithms ... Thrombocythemia #ET #hematology ... #diagnosis #management ... #hematology